Clinical Hepatocellular Carcinoma

The molecular targets of interest have expanded from angiogenesis to cancer cell-directed oncogenic signaling pathways for advanced HCC treatment. The feasibility of combining locoregional therapies and targeted agents, and the use of novel agents after curative treatments are currently under active investigation. Finally, the therapeutic strategy has shifted from monotherapy to combination targeted therapy.

  • Partial Hepatectomy
  • Clinical Analysis of Cells
  • Intra - arterial Chemotherapy
  • AFP Blood Testing

Related Conference of Clinical Hepatocellular Carcinoma

November 18-19, 2019

19th International Conference on Gastroenterology and Hepatology

Hawthorn Suites By Wyndham Abu Dhabi City Center, Abu Dhabi, UAE
November 18-19, 2019

18th International Conference on Gastroenterology and Digestive Disorders

Hawthorn Suites By Wyndham Abu Dhabi City Center, Abu Dhabi, UAE
March 18-19, 2020

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
March 18-19, 2020

11th International conference on Liver and Hepatitis

Amsterdam, Netherlands
March 30-31, 2020

7th International Conference on Hepatology

Osaka, Japan
June 24-25, 2020

15th Euro-Global Gastroenterology Conference

Rome, Italy
July 20-21, 2020

20th World Gastroenterologists Summit

Osaka, Japan
September 28-29. 2020

3rd World Liver Congress

Abu Dhabi, UAE
November 16-17, 2020

30th World Congress on Nursing

Brisbane, Australia
December 07-08 , 2020

International Congress on Gastroenterology and Liver Transplant

Auckland, Newzeland

Clinical Hepatocellular Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in